In the Houston area, testing is currently underway on vaccines that aim to prevent colon cancer. This development is particularly relevant for individuals with Lynch syndrome, a genetic condition that increases the risk of colorectal cancer. A local doctor is participating in the testing of this new vaccine.

It is estimated that approximately 1 million Americans have Lynch syndrome, which is a faulty gene inherited from a parent. This condition not only puts them at high risk of colon cancer but also makes them more susceptible to certain other types of cancer. Further information on this vaccine testing and Lynch syndrome can be found through Houston Public Media.